M. Ajamian, A. M. Rajadhyaksha, and A. Et-alaedini, Autism and Lyme disease--reply, JAMA, issue.8, p.857, 2013.

C. W. Ang, D. W. Notermans, and . Hommes, Large differences between test strategies for the detection of anti-Borrelia antibodies are revealed by comparing eight ELISAs and five immunoblots, European Journal of Clinical Microbiology et Infectious Diseases: Official Publication of the European Society of Clinical Microbiology, vol.30, issue.8, pp.1027-1032, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00702655

,

R. A. Aronowitz, Lyme disease: The social construction of a new disease and its social consequences, The Milbank Quarterly, vol.69, issue.1, pp.79-112, 1991.

R. A. Aronowitz, The Rise and Fall of the Lyme Disease Vaccines : A Cautionary Tale for Risk Interventions in American Medicine and Public Health, The Milbank Quarterly, vol.90, issue.2, pp.250-277, 2012.

, Diagnostic and Statistical Manual of Mental Disorders (DSM-5®), American Psychiatry Association, p.1200, 2013.

, Association of Medical Microbiology and Infectious Disease (AMMI) Canada (24 octobre, 2011.

J. N. Aucott, A. W. Rebman, and L. A. Crowder, Post-treatment Lyme disease syndrome symptomatology and the impact on life functioning: Is there something here?, Quality of Life Research, vol.22, issue.1, pp.75-84, 2013.

P. G. Auwaerter, J. S. Bakken, and R. J. Dattwyler, Antiscience and ethical concerns associated with advocacy of Lyme disease, The Lancet. Infectious Diseases, vol.11, issue.9, pp.713-719, 2011.

, , pp.70034-70036

P. G. Auwaerter and M. T. Et-melia, Bullying Borrelia : When the culture of science is under attack, Transactions of the American Clinical and Climatological Association, vol.123, pp.79-89, 2012.

R. M. Bacon, K. J. Kugeler, P. S. Mead, and . Et, Surveillance for Lyme disease--United States, Morbidity and Mortality Weekly Report. Surveillance Summaries, vol.57, issue.10, pp.1-9, 1992.

R. Banerjee, J. J. Liu, and H. M. Et-minhas, Lyme neuroborreliosis presenting with alexithymia and suicide attempts, Journal of clinical psychiatry, vol.74, issue.10, pp.981-981, 2013.

K. Bär, T. Jochum, and F. Häger, Painful hallucinations and somatic delusions in a patient with the possible diagnosis of neuroborreliosis, The Clinical Journal of Pain, vol.21, issue.4, pp.362-363, 2005.

I. G. Barbosa, C. R. Nogueira, and N. P. Rocha, Altered intracellular signaling cascades in peripheral blood mononuclear cells from BD patients, Journal of Psychiatric Research, vol.47, issue.12, pp.1949-1954, 2013.

W. Barnett, D. Sigmund, and U. Roelcke, , 1991.

, Der Nervenarzt, vol.62, issue.7, pp.445-447

W. B. Barr, R. Rastogi, L. Ravdin, and . Et, Relations among indexes of memory disturbance and depression in patients with Lyme borreliosis, Applied Neuropsychology, vol.6, issue.1, pp.12-18, 1999.

K. T. Bechtold, A. W. Rebman, and L. A. Crowder, Standardized Symptom Measurement of Individuals with Early Lyme Disease Over Time, Archives of Clinical Neuropsychology, vol.32, issue.2, pp.129-141, 2017.

U. Beck, S. Lash, and B. Et-wynne, Risk society : Towards a new modernity, vol.17, p.272, 1992.

W. Beumer, S. M. Gibney, and R. C. Drexhage, The immune theory of psychiatric diseases: A key role for activated microglia and circulating monocytes, Journal of Leukocyte Biology, vol.92, issue.5, pp.959-975, 2012.

A. Bioy, Carl Rogers « Les caractéristiques des relations d'aide, Le développement de la personne, pp.27-43, 1966.

F. Blanc, Épidémiologie de la borréliose et de la neuroborréliose de Lyme en France, vol.165, pp.694-701, 2009.

F. Blanc and . Gebly, , 2007.

, Medecine Et Maladies Infectieuses, vol.37, issue.7-8, pp.435-445

F. Blanc, N. Philippi, and B. Cretin, Lyme neuroborreliosis and dementia, Journal of Alzheimer's Disease: JAD, vol.41, issue.4, pp.1087-1093, 2014.

B. J. Bloom, P. M. Wyckoff, H. C. Meissner, and . Et, Neurocognitive abnormalities in children after classic manifestations of Lyme disease, The Pediatric Infectious Disease Journal, vol.17, issue.3, pp.189-196, 1998.

D. Bouckenaere, La douleur chronique et la relation médecin-malade, Summary. Cahiers de psychologie clinique, vol.28, pp.167-183, 2007.

F. Bourdillon and A. Sobel, L'épidémie de sida : Le temps des transformations. Les Tribunes de la sante, vol.13, pp.53-67, 2006.

R. C. Bransfield, Lyme disease, comorbid tick-borne diseases, and neuropsychiatric disorders, Psychiatric Times, vol.24, issue.14, pp.59-62, 2007.

R. C. Bransfield, The psychoimmunology of lyme/tick-borne diseases and its association with neuropsychiatric symptoms, The Open Neurology Journal, vol.6, pp.88-93, 2012.

,

R. C. Bransfield, Suicide and Lyme and associated diseases, Neuropsychiatric Disease and Treatment, vol.13, pp.1575-1587, 2017.

R. C. Bransfield and M. Et-kuhn, Autism and Lyme disease, JAMA, issue.8, pp.856-857, 2013.

R. C. Bransfield, J. S. Wulfman, and W. T. Harvey, The association between tick-borne infections, Lyme borreliosis and autism spectrum disorders, Medical Hypotheses, vol.70, issue.5, pp.967-974

,

, The epidemiology, prevention, investigation and treatment of Lyme borreliosis in United Kingdom patients : A position statement by the British Infection Association, British Infection Association, vol.62, issue.5, pp.329-338, 2011.

A. S. Brown, Exposure to Prenatal Infection and Risk of Schizophrenia, Frontiers in Psychiatry, vol.2, 2011.

A. S. Brown and P. H. Et-patterson, Maternal Infection and Schizophrenia: Implications for Prevention, Schizophrenia Bulletin, vol.37, issue.2, pp.284-290, 2011.

P. Brown, Popular Epidemiology Revisited. Current Sociology, vol.45, issue.3, pp.137-156, 1997.

P. D. Burbelo, S. E. Swedo, and A. Thurm, Lack of serum antibodies against Borrelia burgdorferi in children with autism, Clinical and Vaccine Immunology: CVI, vol.20, issue.7, pp.1092-1093, 2013.

D. R. Burdge and D. P. Hanlon, Experience at a referral center for patients with suspected Lyme disease in an area of nonendemicity: First 65 patients, Clinical Infectious Diseases, vol.16, issue.4, pp.558-560, 1993.

V. Cairns and J. Et-godwin, Post-Lyme borreliosis syndrome : A meta-analysis of reported symptoms, International Journal of Epidemiology, vol.34, issue.6, pp.1340-1345, 2005.

,

D. J. Cameron, Clinical trials validate the severity of persistent Lyme disease symptoms, Medical Hypotheses, vol.72, issue.2, pp.153-156, 2009.

D. J. Cameron, L. B. Johnson, and E. L. Maloney, Evidence assessments and guideline recommendations in Lyme disease: The clinical management of known tick bites, erythema migrans rashes and persistent disease, Expert Review of Anti-infective Therapy, vol.12, issue.9, pp.1103-1135, 2014.

A. Camus, Sur une philosophie de l'expression, Poésie 44, OEuvres complètes, vol.1, p.908, 1944.

G. Canguilhem, Écrits sur la médecine, p.124, 2002.

G. Canguilhem and . Le, , p.294, 1979.

P. Cathébras, La perspective de la médecine centrée sur la personne : Une condition nécessaire pour apporter une réponse adéquate aux syndromes somatiques fonctionnels, 2017.

, Médecine Interne, vol.38, pp.16-21

L. B. Ceretta, G. Z. Réus, and H. M. Abelaira, Increased prevalence of mood disorders and suicidal ideation in type 2 diabetic patients, Acta Diabetologica, vol.49, issue.1, pp.227-234, 2012.

K. Chabane and E. Et-caumes, Consultations pour maladie de Lyme supposée : Des étiologies très diverses mais pas beaucoup de maladie de Lyme, Médecine et Maladies Infectieuses, vol.48, 2018.

A. M. Chandra, J. G. Keilp, and B. A. Et-fallon, Correlates of perceived health-related quality of life in post-treatment Lyme encephalopathy, Psychosomatics, vol.54, issue.6, pp.552-559, 2013.

,

A. Chandra, G. P. Wormser, and M. S. Klempner, Anti-neural antibody reactivity in patients with a history of Lyme borreliosis and persistent symptoms, Brain, Behavior, and Immunity, vol.24, issue.6, pp.1018-1024, 2010.

J. Chapuis, E. Ferquel, and O. Patey, Borréliose de Lyme: Situation générale et conséquences de l'introduction en Île-de-France d'un nouvel hôte, le tamia de Sibérie, Bulletin épidémiologique hebdomadaire, pp.6-8, 2010.

M. Citera, P. R. Freeman, and R. I. Horowitz, Empirical validation of the Horowitz multiple systemic infectious disease syndrome questionnaire for suspected Lyme disease, International journal of general medicine, vol.10, p.249, 2017.

E. Couturier and H. D. Et-valk, Borréliose de Lyme et autres maladies transmises par les tiques. Lyme borreliosis and other tick-borne diseases, vol.19, p.49, 2018.

A. Créange, Clinical manifestations and epidemiological aspects leading to a diagnosis of Lyme borreliosis: Neurological and psychiatric manifestations in the course of Lyme borreliosis, Medecine Et Maladies Infectieuses, vol.37, issue.7-8, pp.532-539, 2007.

,

G. Csallner, H. Hofmann, and C. Et-hausteiner-wiehle, Patients with « organically unexplained symptoms » presenting to a borreliosis clinic: Clinical and psychobehavioral characteristics and quality of life, Psychosomatics, vol.54, issue.4, pp.359-366, 2013.

,

T. Császár and A. Et-patakfalvi, Differential diagnostic problems in Lyme disease (Borrelia infection resulting in acute exogenous psychosis), Orvosi Hetilap, vol.135, issue.41, pp.2269-2271, 1994.

J. Dahl, H. Ormstad, and H. C. Aass, The plasma levels of various cytokines are increased during ongoing depression and are reduced to normal levels after recovery, 2014.

, Psychoneuroendocrinology, vol.45, pp.77-86

,. De-korwin, L. Chiche, and I. Banovic, Le syndrome de fatigue chronique : Une nouvelle maladie ? La Revue de Médecine Interne, vol.37, pp.811-819, 2016.

,

R. Dersch, H. Sommer, and S. Rauer, Prevalence and spectrum of residual symptoms in Lyme neuroborreliosis after pharmacological treatment: A systematic review, Journal of Neurology, vol.263, issue.1, pp.17-24, 2016.

R. Dersch, M. H. Freitag, and S. Schmidt, Efficacy and safety of pharmacological treatments for neuroborreliosis--protocol for a systematic review, Systematic Reviews, vol.3, 2014.

R. Dersch, A. Sarnes, and M. Maul, Quality of life, fatigue, depression and cognitive impairment in Lyme neuroborreliosis, Journal of Neurology, vol.262, issue.11, pp.2572-2577, 2015.

,

J. Desenclos, L'élaboration des recommandations de prise en charge de la maladie de Lyme : un nécessaire questionnement éthique, Bulletin Epidemiologique Hebdomadaire, issue.14, p.24, 2019.

, Borréliose de Lyme Diagnostic biologique. Le point sur Risques infectieux Zoonoses, 2015.

M. Djukic, C. Schmidt-samoa, and R. Nau, The diagnostic spectrum in patients with suspected chronic Lyme neuroborreliosis--the experience from one year of a university hospital's Lyme neuroborreliosis outpatients clinic, European Journal of Neurology, vol.18, issue.4, pp.547-555, 2011.

S. T. Donta, R. B. Noto, and J. A. Vento, SPECT brain imaging in chronic Lyme disease, Clinical Nuclear Medicine, vol.37, issue.9, pp.219-222, 2012.

Y. Dowlati, N. Herrmann, and W. Swardfager, A meta-analysis of cytokines in major depression, Biological Psychiatry, vol.67, issue.5, pp.446-457, 2010.

,

W. El-hage, C. Lamy, and P. Goupille, Fibromyalgie : Une maladie du traumatisme psychique? La Presse Médicale, vol.35, pp.74881-74884, 2006.

L. E. Elkins, D. A. Pollina, and S. R. Scheffer, Psychological states and neuropsychological performances in chronic Lyme disease, Applied Neuropsychology, vol.6, issue.1, pp.19-26, 1999.

M. E. Embers, S. W. Barthold, and J. T. Borda, Persistence of Borrelia burgdorferi in rhesus macaques following antibiotic treatment of disseminated infection, PloS One, vol.7, issue.1, 2012.

M. E. Embers, N. R. Hasenkampf, and M. B. Jacobs, Variable manifestations, diverse seroreactivity and post-treatment persistence in non-human primates exposed to Borrelia burgdorferi by tick feeding, PloS One, vol.12, issue.12, 2017.

G. L. Engel, The need for a new medical model : A challenge for biomedicine, Science, issue.4286, pp.129-136, 1977.

M. Erta, A. Quintana, and J. Hidalgo, Interleukin-6, a major cytokine in the central nervous system, International Journal of Biological Sciences, vol.8, issue.9, pp.1254-1266, 2012.

,

J. Evans, Lyme disease, Current Opinion in Rheumatology, vol.6, issue.4, pp.415-422, 1994.

B. A. Fallon, J. M. Kochevar, and A. Gaito, The underdiagnosis of neuropsychiatric Lyme disease in children and adults. The Psychiatric Clinics of North America, vol.21, pp.693-703, 1998.

B. A. Fallon and J. A. Et-nields, Lyme disease: A neuropsychiatric illness, The American Journal of Psychiatry, vol.151, issue.11, pp.1571-1583, 1994.

B. A. Fallon, J. A. Nields, and J. J. Burrascano, The neuropsychiatric manifestations of Lyme borreliosis, The Psychiatric Quarterly, vol.63, issue.1, pp.95-117, 1992.

B. A. Fallon, J. A. Nields, and B. Parsons, Psychiatric manifestations of Lyme borreliosis, The Journal of Clinical Psychiatry, vol.54, issue.7, pp.263-268, 1993.

B. A. Fallon, M. Schwartzberg, and R. Bransfield, Late-stage neuropsychiatric Lyme borreliosis. Differential diagnosis and treatment, Psychosomatics, vol.36, issue.3, pp.295-300, 1995.

, , pp.71669-71672

J. Fallon, D. I. Bujak, and S. Guardino, The Fibromyalgia Impact Questionnaire : a useful tool in evaluating patients with post-Lyme disease syndrome, Arthritis Care & Research, vol.12, issue.1, pp.42-47, 1999.

J. Fallon, A. Brian, and R. B. Lipkin, Regional cerebral blood flow and metabolic rate in persistent Lyme encephalopathy, Archives of General Psychiatry, vol.66, issue.5, pp.554-563, 2009.
URL : https://hal.archives-ouvertes.fr/hal-01086814

,

J. Fallon, A. Brian, and E. Petkova, A reappraisal of the u.s. Clinical trials of post-treatment lyme disease syndrome, The Open Neurology Journal, vol.6, pp.79-87, 2012.

,

H. M. Feder, B. J. Johnson, and S. O'connell, A critical appraisal of « chronic Lyme disease, The New England Journal of Medicine, vol.357, issue.14, pp.1422-1430, 2007.

,

G. Fond, Inflammation in psychiatric disorders, European Psychiatry, vol.29, issue.8, pp.551-552, 2014.

G. Fond, N. Hamdani, and F. Kapczinski, Effectiveness and tolerance of anti-inflammatory drugs' add-on therapy in major mental disorders: A systematic qualitative review, Acta Psychiatrica Scandinavica, vol.129, issue.3, pp.163-179, 2014.

M. Foucault, Il faut défendre la société. Cours au Collège de France, p.283, 1976.

L. Fournier, V. Roussel, and E. Couturier, Épidémiologie de la borréliose de Lyme en médecine générale, France métropolitaine, Bull Epidémiol Hebd, pp.19-20, 2009.

M. G. Frank, M. V. Baratta, and D. B. Sprunger, Microglia serve as a neuroimmune substrate for stress-induced potentiation of CNS pro-inflammatory cytokine responses, Brain, Behavior, and Immunity, vol.21, issue.1, pp.47-59, 2007.

M. Fritzsche, Geographical and seasonal correlation of multiple sclerosis to sporadic schizophrenia, International Journal of Health Geographics, vol.1, issue.1, p.5, 2002.

H. Gao and J. Hong, Why neurodegenerative diseases are progressive : Uncontrolled inflammation drives disease progression, Trends in Immunology, vol.29, issue.8, pp.357-365, 2008.

,

A. Garakani and A. G. Et-mitton, New-onset panic, depression with suicidal thoughts, and somatic symptoms in a patient with a history of lyme disease, Case Reports in Psychiatry, p.457947, 2015.

E. A. Gaudino, P. K. Coyle, and L. B. Et-krupp, Post-Lyme syndrome and chronic fatigue syndrome. Neuropsychiatric similarities and differences, Archives of Neurology, vol.54, issue.11, pp.1372-1376, 1997.

R. R. Girgis, S. S. Kumar, and A. S. Et-brown, The cytokine model of schizophrenia: Emerging therapeutic strategies, Biological Psychiatry, vol.75, issue.4, pp.292-299, 2014.

,

P. Goines and J. Et-van-de-water, The immune system's role in the biology of autism, Current Opinion in Neurology, vol.23, issue.2, pp.111-117, 2010.

R. Gori and M. Vogo, La Santé totalitaire Essai sur la médicalisation de l'existence, vol.4, pp.133-136, 2005.

H. J. Grabe, C. Spitzer, and J. Lüdemann, No association of seropositivity for anti-Borrelia IgG antibody with mental and physical complaints, Nordic Journal of Psychiatry, vol.62, issue.5, pp.386-391, 2008.

H. E. Greenberg, G. Ney, and S. M. Scharf, Sleep quality in Lyme disease, Sleep, vol.18, issue.10, pp.912-916, 1995.

T. Hájek, B. Pasková, and D. Janovská, Higher prevalence of antibodies to Borrelia burgdorferi in psychiatric patients than in healthy subjects, The American Journal of Psychiatry, vol.159, issue.2, pp.297-301, 2002.

J. J. Halperin, E. D. Shapiro, and E. Logigian, Practice parameter: Treatment of nervous system Lyme disease (an evidence-based review): report of the Quality Standards Subcommittee of the, Neurology, vol.69, issue.1, pp.91-102, 2007.

,

J. J. Halperin, P. Baker, and G. P. Et-wormser, Common misconceptions about Lyme disease, The American Journal of Medicine, vol.126, issue.3, pp.1-7, 2013.

,

J. Hannestad, N. Dellagioia, and M. Et-bloch, The effect of antidepressant medication treatment on serum levels of inflammatory cytokines : A meta-analysis, Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology, vol.36, issue.12, pp.2452-2459, 2011.

Y. Hansmann, C. Chirouze, and P. Tattevin, Position de la Société de pathologie infectieuse de langue française à propos de la maladie de Lyme, Médecine et Maladies Infectieuses, vol.46, pp.343-345, 2016.

Y. Hansmann, C. Leyer, and N. Lefebvre, Feedback on difficulties raised by the interpretation of serological tests for the diagnosis of Lyme disease, Médecine et Maladies Infectieuses, vol.44, pp.199-205, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01491155

A. L. Hassett, D. C. Radvanski, and S. Buyske, Role of psychiatric comorbidity in chronic Lyme disease, Arthritis and Rheumatism, vol.59, issue.12, pp.1742-1749, 2008.

A. L. Hassett, D. C. Radvanski, and S. Buyske, Psychiatric comorbidity and other psychological factors in patients with « chronic Lyme disease, The American Journal of Medicine, vol.122, issue.9, pp.843-850, 2009.

, Mieux connaître la borréliose de Lyme pour mieux la prévenir. Commission spécialisée « Maladies transmissibles, 2010.

, Rapport du groupe de travail -La borréliose de Lyme, 2014.

, Avis relatif à la borréliose de Lyme, 2016.

, Actualisation des connaissances sur le risque de transmission des Borrelia via les produits sanguins labiles ou les greffes, 2017.

, Épisode dépressif caractérisé de l'adulte : prise en charge en premier recours, 2017.

, Borréliose de Lyme et autres maladies vectorielles à tiques (MVT), 2018.

, Symptomatologie/Syndrome persistant(e) polymorphe après une possible piqûre de tique (SPPT), Haute Autorité de Santé (HAS), 2018.

, Lyme et autres maladies vectorielles à tiques

C. Hazif-thomas and C. Et-hanon, Profanes, soignants et santé mentale : Quelle ingérence ? Doin -John Libbey Eurotext, p.248, 2015.

C. Heim, U. Ehlert, and D. H. Et-hellhammer, The potential role of hypocortisolism in the pathophysiology of stress-related bodily disorders, Psychoneuroendocrinology, vol.25, issue.1, pp.1-35, 2000.

, , pp.35-44

B. Helon, T. W. T?uczek, and A. Buczyjan, , 2009.

, Psychiatria Polska, vol.43, issue.3, pp.353-361

A. Hess, J. Buchmann, and U. K. Zettl, Borrelia burgdorferi central nervous system infection presenting as an organic schizophrenialike disorder, Biological Psychiatry, vol.45, issue.6, p.795, 1999.

E. Hodzic, S. Feng, and K. Holden, Persistence of Borrelia burgdorferi following Antibiotic Treatment in Mice, Antimicrobial Agents and Chemotherapy, vol.52, issue.5, pp.1728-1736, 2008.

,

A. Hofhuis, M. Harms, and C. Van-den-wijngaard, Continuing increase of tick bites and Lyme disease between 1994 and 2009. Ticks and tick-borne diseases, vol.6, pp.69-74, 2015.

,

H. Hong, B. S. Kim, and H. Et-im, Pathophysiological Role of Neuroinflammation in Neurodegenerative Diseases and Psychiatric Disorders, International Neurourology Journal, vol.20, issue.1, pp.2-7, 2016.

M. Hornig, H. Weissenböck, and N. Horscroft, An infection-based model of neurodevelopmental damage, Proceedings of the National Academy of Sciences, vol.96, pp.12102-12107, 1999.

R. Horowitz, Soigner Lyme et les maladies chroniques inexpliquées, Axis Mediasciences T. Souccar, p.576, 2014.

M. B. Howren, D. M. Lamkin, and J. Et-suls, Associations of depression with C-reactive protein, IL-1, and IL-6: A meta-analysis, Psychosomatic Medicine, vol.71, issue.2, pp.171-186, 2009.

,

Z. Hubálek, Epidemiology of Lyme Borreliosis, Lyme Borreliosis, vol.37, pp.31-50, 2009.

P. Humair and L. Et-gern, The wild hidden face of Lyme borreliosis in Europe, Microbes and Infection, vol.2, issue.8, pp.915-922, 2000.

R. A. Hurley and K. H. Taber, Acute and chronic Lyme disease: Controversies for neuropsychiatry, The Journal of Neuropsychiatry and Clinical Neurosciences, vol.20, issue.1, p.6, 2008.

, Autopsie psychologique : Mise en oeuvre et démarches associées, 2008.

, Décès par suicide et hospitalisations pour tentative de suicide en région, 2018.

, Interprétation d'un test sérologique lors d'une suspicion de borréliose de Lyme -Points sur les connaissances -Borréliose de Lyme

, Données épidémiologiques -Borréliose de Lyme, 2018.

L. Jacobson and A. J. Et-mariano, General consideration on chronic pain, Bonica's Management of Pain, 2001.

C. Jacquet, F. Goehringer, and E. Baux, Multidisciplinary management of patients presenting with Lyme disease suspicion, Médecine et Maladies Infectieuses, vol.49, pp.112-120, 2019.

,

B. Jaulhac, F. Twizeyimana, and . Schamm, , p.94, 2017.

F. Jouda, J. Perret, and L. Et-gern, Density of Questing Ixodes ricinus Nymphs and Adults Infected by Borrelia burgdorferi Sensu Lato in Switzerland: Spatio-Temporal Pattern at a Regional Scale. Vector-Borne and Zoonotic Diseases, vol.4, pp.23-32, 2004.

,

D. Juchnowicz, I. Rudnik, and A. Czernikiewicz, Przeglad Epidemiologiczny, vol.56, issue.1, pp.37-50, 2002.

R. A. Kalish, R. F. Kaplan, and E. Taylor, Evaluation of study patients with Lyme disease, 10-20-year follow-up, The Journal of Infectious Diseases, vol.183, issue.3, pp.453-460, 2001.

,

R. F. Kaplan, L. Jones-woodward, and K. Workman, Neuropsychological deficits in Lyme disease patients with and without other evidence of central nervous system pathology, Applied Neuropsychology, vol.6, issue.1, pp.3-11, 1999.

R. F. Kaplan, M. E. Meadows, and L. C. Vincent, Memory impairment and depression in patients with Lyme encephalopathy: Comparison with fibromyalgia and nonpsychotically depressed patients, Neurology, vol.42, issue.7, pp.1263-1267, 1992.

W. R. Keller, L. M. Kum, and H. J. Wehring, A review of anti-inflammatory agents for symptoms of schizophrenia, Journal of Psychopharmacology, vol.27, issue.4, pp.337-342, 2013.

L. Kepa, B. Oczko-grzesik, and T. Et-badura-glombik, , 2008.

, Przeglad Epidemiologiczny, vol.62, issue.4, pp.793-800

B. Kirkpatrick and B. J. Miller, Inflammation and schizophrenia, Schizophrenia Bulletin, vol.39, issue.6, pp.1174-1179, 2013.

K. E. Kisand, T. Prükk, and K. V. Kisand, Propensity to excessive proinflammatory response in chronic Lyme borreliosis, APMIS, vol.115, issue.2, pp.134-141, 2007.

M. S. Klempner, L. T. Hu, and J. Evans, Two Controlled Trials of Antibiotic Treatment in Patients with Persistent Symptoms and a History of Lyme Disease, New England Journal of Medicine, vol.345, issue.2, pp.85-92, 2001.

H. H. Kollikowski, G. Schwendemann, and M. Schulz, Chronic borrelia encephalomyeloradiculitis with severe mental disturbance: Immunosuppressive versus antibiotic therapy, Journal of Neurology, vol.235, issue.3, pp.140-142, 1988.

M. M. Koola, K. M. Sullivan, and A. K. Earl, Undiagnosed Lyme disease in adults with schizophrenia, Schizophrenia Research, vol.168, issue.1-2, pp.579-580, 2015.

,

. Kouchner, LOI n° 2002-303 du 4 mars 2002 relative aux droits des malades et à la qualité du système de santé, pp.2002-303, 2002.

L. B. Krupp, D. Masur, and J. Schwartz, Cognitive functioning in late Lyme borreliosis, Archives of Neurology, vol.48, issue.11, pp.1125-1129, 1991.

M. Kuhn and R. Et-bransfield, Divergent opinions of proper Lyme disease diagnosis and implications for children co-morbid with autism spectrum disorder, Medical Hypotheses, vol.83, issue.3, pp.321-325, 2014.

M. Kuhn, S. Grave, and R. Bransfield, Long term antibiotic therapy may be an effective treatment for children co-morbid with Lyme disease and autism spectrum disorder, Medical Hypotheses, vol.78, issue.5, pp.606-615, 2012.

K. Kurtenbach, K. Hanincová, and J. I. Tsao, Fundamental processes in the evolutionary ecology of Lyme borreliosis, Nature Reviews. Microbiology, vol.4, issue.9, pp.660-669, 2006.

,

P. M. Lantos, P. G. Auwaerter, and G. P. Wormser, A systematic review of Borrelia burgdorferi morphologic variants does not support a role in chronic Lyme disease, vol.58, pp.663-671, 2014.

F. Laroche, La fibromyalgie : Diagnostic positif, diagnostics différentiels et diagnostics associés, Revue du Rhumatisme Monographies, vol.85, issue.4, pp.287-294, 2018.

,

F. Laroche, La fibromyalgie : Diagnostic positif, diagnostics différentiels et diagnostics associés, 2018.

L. Belle, J. E. Sperry, J. Ngo, and A. , Maternal inflammation contributes to brain overgrowth and autism-associated behaviors through altered redox signaling in stem and progenitor cells, Stem Cell Reports, vol.3, issue.5, pp.725-734, 2014.

,

C. Lefève, De la philosophie de la médecine de Georges Canguilhem à la philosophie du soin médical. Revue de metaphysique et de morale, , vol.82, issue.2, pp.197-221, 2014.

M. Legatowicz-koprowska, A. I. Gziut, and E. Walczak, , 2008.

L. Polski-merkuriusz, Organ Polskiego Towarzystwa Lekarskiego, vol.24, issue.143, pp.433-435

. Leitlinien, Diagnostik und Therapie der Lyme-Borreliose, 2011.

E. Lindgren, T. Jaenson, and B. Menne, Lyme borreliosis in Europe : Influences of climate and climate change, epidemiology, ecology and adaptation measures. Consulté à l'adresse Copenhagen: WHO Regional Office for, Europe, 2006.

M. Lindgren, M. Torniainen-holm, and T. Härkänen, The association between toxoplasma and the psychosis continuum in a general population setting, Schizophrenia Research, vol.193, pp.329-335, 2018.

D. Lindqvist, S. Janelidze, and P. Hagell, Interleukin-6 is elevated in the cerebrospinal fluid of suicide attempters and related to symptom severity, Biological Psychiatry, vol.66, issue.3, pp.287-292, 2009.

V. J. Ling, D. Lester, and P. B. Mortensen, Toxoplasma gondii seropositivity and suicide rates in women, The Journal of Nervous and Mental Disease, vol.199, issue.7, pp.440-444, 2011.

,

U. Ljøstad and Å. Et-mygland, The phenomenon of « chronic Lyme » ; an observational study, European Journal of Neurology, vol.19, issue.8, pp.1128-1135, 2012.

C. Luthy, N. Cedraschi, and A. De-tonnac, Symptômes médicalement inexpliqués en médecine interne : Recommandations pour la prise en charge hospitalière, Revue Médicale Suisse, vol.1, 2003.

M. M. Macauda, P. Erickson, and J. Miller, Long-Term Lyme Disease Antibiotic Therapy Beliefs Among New England Residents. Vector-Borne and Zoonotic Diseases, vol.11, pp.857-862, 2011.

K. L. Macdonald, M. T. Osterholm, and K. H. Ledell, A case-control study to assess possible triggers and cofactors in chronic fatigue syndrome, The American Journal of Medicine, vol.100, issue.5, pp.548-554, 1996.

N. Makhani, S. K. Morris, and A. V. Page, A twist on Lyme : The challenge of diagnosing European Lyme neuroborreliosis, Journal of Clinical Microbiology, vol.49, issue.1, pp.455-457, 2011.

,

A. Marangoni, M. Sparacino, and F. Cavrini, Comparative evaluation of three different ELISA methods for the diagnosis of early culture-confirmed Lyme disease in Italy, Journal of Medical Microbiology, vol.54, issue.4, pp.361-367, 2005.

J. Markeljevi?, H. Sarac, and M. Et-rados, Tremor, seizures and psychosis as presenting symptoms in a patient with chronic lyme neuroborreliosis (LNB), Collegium Antropologicum, vol.35, issue.1, pp.313-318, 2011.

A. Marques, Chronic Lyme Disease: An appraisal, Infectious disease clinics of North America, vol.22, issue.2, pp.341-360, 2008.

A. R. Marques, F. Stock, and V. Gill, Evaluation of a new culture medium for Borrelia burgdorferi, Journal of Clinical Microbiology, vol.38, issue.11, pp.4239-4241, 2000.

S. L. Marzillier, Why psychologists need to know about Lyme disease, Clinical Psychology Forum, vol.194, pp.37-41, 2009.

D. W. Mattingley and M. M. Et-koola, Association of Lyme Disease and Schizoaffective Disorder, Bipolar Type : Is it Inflammation Mediated?, Indian Journal of Psychological Medicine, vol.37, issue.2, pp.243-246, 2015.

C. Maud and M. Berk, Neuropsychiatric presentation of Lyme disease in Australia, The Australian and New Zealand Journal of Psychiatry, vol.47, issue.4, pp.397-398, 2013.

,

R. Melzack, The short-form McGill pain questionnaire, Pain, vol.30, issue.2, pp.191-197, 1987.

L. Meriläinen, H. Brander, and A. Herranen, Pleomorphic forms of Borrelia burgdorferi induce distinct immune responses, Microbes and Infection, vol.18, issue.7-8, pp.484-495, 2016.

,

U. Meyer, Developmental neuroinflammation and schizophrenia, Progress in Neuro-Psychopharmacology et Biological Psychiatry, vol.42, pp.20-34, 2013.

,

J. Miklossy, Analysis of the evidence following Koch's and Hill's criteria, Journal of Neuroinflammation, vol.8, p.90, 2011.

J. H. Miles, Autism spectrum disorders--a genetics review, Genetics in Medicine: Official Journal of the American College of Medical Genetics, vol.13, issue.4, pp.278-294, 2011.

,

A. H. Miller, V. Maletic, and C. L. Et-raison, Inflammation and its discontents: The role of cytokines in the pathophysiology of major depression, Biological Psychiatry, vol.65, issue.9, pp.732-741, 2009.

,

A. H. Miller and C. L. Et-raison, Are Anti-inflammatory Therapies Viable Treatments for Psychiatric Disorders?: Where the Rubber Meets the Road, vol.72, pp.527-528, 2015.

,

B. J. Miller, P. Buckley, and W. Seabolt, Meta-analysis of cytokine alterations in schizophrenia : Clinical status and antipsychotic effects, Biological Psychiatry, vol.70, issue.7, pp.663-671, 2011.

S. Ministère-des, L. De, and . Santé, Maladie de Lyme, 2019.

H. Moldofsky, Sleep, neuroimmune and neuroendocrine functions in fibromyalgia and chronic fatigue syndrome, Advances in Neuroimmunology, vol.5, issue.1, pp.39-56, 1995.

X. Monfrim, M. Gazal, and P. B. Leon, Immune dysfunction in bipolar disorder and suicide risk: Is there an association between peripheral corticotropin-releasing hormone and interleukin-1??, Bipolar Disorders, vol.16, issue.7, pp.741-747, 2014.

A. Moniuszko, P. Czupryna, and J. Zajkowska, , 2009.

L. Polski-merkuriusz, Organ Polskiego Towarzystwa Lekarskiego, vol.26, issue.153, pp.227-230

A. Monji, T. Kato, and S. Et-kanba, Cytokines and schizophrenia: Microglia hypothesis of schizophrenia, Psychiatry and clinical neurosciences, vol.63, issue.3, pp.257-265, 2009.

J. T. Morgan, G. Chana, and I. Abramson, Abnormal microglial-neuronal spatial organization in the dorsolateral prefrontal cortex in autism, Brain Research, vol.1456, pp.72-81, 2012.

,

C. R. Mortensen, D. V. Becker, and J. M. Ackerman, Infection breeds reticence: The effects of disease salience on self-perceptions of personality and behavioral avoidance tendencies, Psychological Science, vol.21, issue.3, pp.440-447, 2010.

,

N. Müller, E. Weidinger, and B. Leitner, The role of inflammation in schizophrenia, Frontiers in Neuroscience, vol.9, 2015.

R. B. Nadelman, E. Herman, and G. P. Et-wormser, Screening for Lyme disease in hospitalized psychiatric patients : Prospective serosurvey in an endemic area, The Mount Sinai Journal of Medicine, vol.64, issue.6, pp.409-412, 1997.

R. B. Nadelman, K. Hanincová, and P. Mukherjee, Differentiation of Reinfection from Relapse in Recurrent Lyme Disease, New England Journal of Medicine, vol.367, issue.20, pp.1883-1890, 2012.

R. B. Nadelman, J. Nowakowski, and G. Forseter, Failure to isolate Borrelia burgdorferi after antimicrobial therapy in culture-documented Lyme borreliosis associated with erythema migrans: Report of a prospective study, The American journal of medicine, vol.94, issue.6, pp.583-588, 1993.

S. Najjar and D. M. Et-pearlman, Neuroinflammation and white matter pathology in schizophrenia: Systematic review, Schizophrenia Research, vol.161, issue.1, pp.102-112, 2015.

,

, National Guideline Clearinghouse (NGC). (05/10/2014). FAQ

C. A. Nelson, S. Saha, and K. J. Kugeler, Incidence of Clinician-Diagnosed Lyme Disease, Emerging Infectious Diseases, vol.21, issue.9, pp.1625-1631, 2005.

,

K. J. Neumärker, U. Dudeck, and P. Et-plaza, , 1989.

, Der Nervenarzt, vol.60, issue.2, pp.115-119

R. Nitrini, Clinical and therapeutic aspects of dementia in syphilis and Lyme disease, Handbook of Clinical Neurology, vol.89, pp.1271-1278, 2008.

C. Notredame, N. Pauwels, and M. Walter, Presse medicale, pp.1243-1250, 1983.

J. Nowakowski, R. B. Nadelman, and R. Sell, Long-term follow-up of patients with culture-confirmed Lyme disease, The American Journal of Medicine, vol.115, issue.2, pp.91-96, 2003.

S. M. O'brien, P. Scully, and P. Fitzgerald, Plasma cytokine profiles in depressed patients who fail to respond to selective serotonin reuptake inhibitor therapy, Journal of Psychiatric Research, vol.41, issue.3, pp.326-331, 2007.

S. O'connell, Action Concertée Européenne sur la Borréliose de Lyme (EUCALB), 1996.

, Eurosurveillance, vol.1, issue.3, pp.23-24

B. Oczko-grzesik, L. K?pa, and M. Puszcz-matli?ska, Estimation of cognitive and affective disorders occurrence in patients with Lyme borreliosis, Annals of Agricultural and Environmental Medicine, vol.24, issue.1, pp.33-38, 2017.

Y. Ohgi, T. Futamura, and T. Kikuchi, Effects of antidepressants on alternations in serum cytokines and depressive-like behavior in mice after lipopolysaccharide administration, Biochemistry, and Behavior, vol.103, issue.4, pp.853-859, 2013.

,

J. Oksi, H. Kalimo, and R. J. Marttila, Inflammatory brain changes in Lyme borreliosisA report on three patients and review of literature, Brain, vol.119, issue.6, pp.2143-2154, 1996.

,

, Classification internationale des maladies, 1994.

, Chapitre V (F) : troubles mentaux et troubles du comportement. Critères diagnostiques pour la recherche. Dixième révision

, 10 faits sur la santé mentale, 2014.

C. Onore, M. Careaga, and P. Et-ashwood, The role of immune dysfunction in the pathophysiology of autism, Brain, Behavior, and Immunity, vol.26, issue.3, pp.383-392, 2012.

,

T. Papo, Certains symptômes cliniques aspécifiques ont-ils une origine borrélienne?, Médecine et Maladies Infectieuses, vol.37, pp.507-510, 2007.

A. R. Pasareanu, Å. Mygland, and Ø. Et-kristensen, A woman in her 50s with manic psychosis, Tidsskrift for Den Norske Laegeforening: Tidsskrift for Praktisk Medicin, vol.132, pp.537-539, 2012.

P. Peretti-watel, J. Ward, and R. Lutaud, Lyme disease: Insight from social sciences, Médecine et Maladies Infectieuses, vol.49, pp.133-139, 2019.
URL : https://hal.archives-ouvertes.fr/hal-02263659

,

S. Perrot, D. Bouhassira, and J. Et-fermanian, Development and validation of the fibromyalgia rapid screening tool (FiRST), Pain, vol.150, issue.2, pp.250-256, 2010.

H. W. Pfister and T. A. Et-rupprecht, Clinical aspects of neuroborreliosis and post-Lyme disease syndrome in adult patients, International Journal of Medical Microbiology: IJMM, vol.296, pp.11-16, 2006.

H. W. Pfister, V. Preac-mursic, and B. Wilske, Catatonic syndrome in acute severe encephalitis due to Borrelia burgdorferi infection, Neurology, vol.43, issue.2, pp.433-433, 1993.

A. C. Phillips, D. Carroll, and G. Et-der, Negative life events and symptoms of depression and anxiety: Stress causation and/or stress generation, Stress, and Coping, vol.28, issue.4, pp.357-371, 2015.

,

D. P. Phillips, The Werther effect, 1985.

P. Planche and M. Et-botbol, Maladie de Lyme, syndrome autistique et traitement antibiotique : Une réflexion à partir d'un cas. Annales Médico-psychologiques, revue psychiatrique, vol.171, pp.711-715, 2013.

T. Pollmächer, M. Haack, and A. Schuld, Effects of antipsychotic drugs on cytokine networks, Journal of Psychiatric Research, vol.34, issue.6, pp.369-382, 2000.

R. Pop?awska, A. Szulc, and J. Zajkowska, , 1999.

, Psychiatria Polska, vol.33, issue.2, pp.241-250

S. Potvin, E. Stip, and A. A. Sepehry, Inflammatory cytokine alterations in schizophrenia: A systematic quantitative review, Biological Psychiatry, vol.63, issue.8, pp.801-808, 2008.

,

D. Pourette, Janine Barbot, Les Malades en mouvements. La médecine et la science à l'épreuve du sida, Voix et regards »). L'Homme. Revue française d'anthropologie, vol.307, pp.188-190, 2002.

V. Rabeharisoa and J. Barbot, Les malades en mouvements. La médecine et la science à l'épreuve du sida. Politix. Revue des sciences sociales du politique, vol.16, pp.219-223, 2003.

M. Rachman and D. A. Garfield, Lyme disease and secondary depression: Universal lessons from an uncommon case, Psychosomatics, vol.39, issue.3, pp.71353-71355, 1998.

I. Rapin, Autism. The New England Journal of Medicine, vol.337, issue.2, pp.97-104, 1997.

A. W. Rebman, K. T. Bechtold, and T. Yang, The clinical, symptom, and quality of life characterization of a well-defined group of patients with post-treatment Lyme disease syndrome, Frontiers in medicine, vol.4, p.224, 2017.

M. C. Reid, The Consequences of Overdiagnosis and Overtreatment of Lyme Disease: An Observational Study, Annals of Internal Medicine, vol.128, issue.5, p.354, 1998.

G. Z. Réus, G. R. Fries, and L. Stertz, The role of inflammation and microglial activation in the pathophysiology of psychiatric disorders, Neuroscience, vol.300, pp.141-154, 2015.

,

R. Signorat, A. Et-gonnet, and F. , Vécu et représentations de la maladie des patients pensant être atteints de la maladie de Lyme (Thèse d'exercice), 2014.

A. Rizzoli, H. Hauffe, and G. Carpi, Lyme borreliosis in Europe, Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles, issue.27, p.16, 2011.

M. L. Roche, F. Ader, and M. C. Durand, , 2008.

, Medecine et maladies infectieuses, vol.38, issue.10, pp.543-548

U. Roelcke, W. Barnett, and E. Wilder-smith, Untreated neuroborreliosis: Bannwarth's syndrome evolving into acute schizophrenia-like psychosis. A case report, Journal of Neurology, vol.239, issue.3, pp.129-131, 1992.

J. D. Rosenblat, D. S. Cha, and R. B. Mansur, Inflamed moods: A review of the interactions between inflammation and mood disorders, Progress in Neuro-Psychopharmacology et Biological Psychiatry, vol.53, pp.23-34, 2014.

,

I. Rudnik-sza?aj, R. Pop?awska, and J. Zajkowska, , 2001.

L. Polski-merkuriusz, Organ Polskiego Towarzystwa Lekarskiego, vol.11, issue.65, pp.460-462

D. L. Sackett, W. M. Rosenberg, J. M. Gray, R. B. Haynes, and W. S. Richardson, Evidence based medicine, BMJ: British Medical Journal, vol.313, issue.7050, p.170, 1996.

J. Salomon, The Lyme disease plan of the French Directorate General for Health, Médecine et Maladies Infectieuses, vol.49, pp.81-82, 2019.

Y. O. Sanogo, Z. Zeaiter, and G. Caruso, Bartonella henselae in Ixodes ricinus Ticks (Acari: Ixodida) Removed from Humans, vol.9, pp.329-332, 2003.

E. Sapi, N. Kaur, and S. Anyanwu, Evaluation of in-vitro antibiotic susceptibility of different morphological forms of Borrelia burgdorferi, Infection and Drug Resistance, vol.4, pp.97-113, 2011.

G. Savard, Enjeux et limites de la médecine factuelle (Evidence-based medicine) Mémoire de DEA en éthique médicale et biologique, 2003.

O. J. Schiepers, M. C. Wichers, and M. Maes, Cytokines and major depression, Progress in Neuro-Psychopharmacology et Biological Psychiatry, vol.29, issue.2, pp.201-217, 2005.

,

M. L. Schroeter, J. Steiner, and K. Mueller, Glial pathology is modified by age in mood disorders--a systematic meta-analysis of serum S100B in vivo studies, Journal of Affective Disorders, vol.134, issue.1-3, pp.32-38, 2011.

. Schumacher, L'éthique de la dépendance face au corps vulnérable, Erès, p.320, 2019.

S. E. Schutzer and B. H. Et-natelson, Absence of Borrelia burgdorferi-specific immune complexes in chronic fatigue syndrome, Neurology, vol.53, issue.6, pp.1340-1340, 1999.

,

A. Septfons, Borréliose de Lyme : Estimation de l'incidence hospitalière en France de 2005 à 2016 / Lyme Borreliosis : Estimated hospital incidence in France from, vol.19, p.7, 2005.

N. A. Shadick, C. B. Phillips, and E. L. Logigian, The long-term clinical outcomes of Lyme disease. A population-based retrospective cohort study, Annals of Internal Medicine, vol.121, issue.8, pp.560-567, 1994.

V. T. Sherr, Panic attacks may reveal previously unsuspected chronic disseminated lyme disease, Journal of Psychiatric Practice, vol.6, issue.6, pp.352-356, 2000.

L. H. Sigal, Summary of the first 100 patients seen at a Lyme disease referral center, The American Journal of Medicine, vol.88, issue.6, pp.577-581, 1990.

P. Slovic, Perception of risk, Science, vol.236, issue.4799, pp.280-285, 1987.

B. Smart, Reviews : Ulrich Beck, Risk Society : Towards a New Modernity, vol.37, pp.160-165, 1992.

,

S. E. Smith, J. Li, K. Garbett, and K. Mirnics, Maternal immune activation alters fetal brain development through interleukin-6, The Journal of Neuroscience : The Official Journal of the Society for Neuroscience, vol.27, issue.40, pp.10695-10702, 2007.

,

H. N. Sno, Signs and significance of a tick-bite : Psychiatric disorders associated with Lyme disease, 2012.

, Tijdschrift Voor Psychiatrie, vol.54, issue.3, pp.235-243

S. P. Solomon, E. Hilton, and B. S. Weinschel, Psychological factors in the prediction of Lyme disease course. Arthritis Care and Research: The Official Journal of the Arthritis Health Professions Association, vol.11, pp.419-426, 1998.

, Borréliose de Lyme : démarches diagnostiques, thérapeutiques et préventives. 17, 2006.

G. Stanek, G. P. Wormser, and J. Gray, Lyme borreliosis, Lancet, issue.9814, pp.60103-60110, 2012.

A. C. Steere, E. Taylor, and G. L. Mchugh, The overdiagnosis of Lyme disease, JAMA, vol.269, issue.14, pp.1812-1816, 1993.

A. C. Steere, J. Coburn, and L. Et-glickstein, The emergence of Lyme disease, The Journal of Clinical Investigation, vol.113, issue.8, pp.1093-1101, 2004.

S. L. Stein, H. B. Solvason, and E. Biggart, A 25-year-old woman with hallucinations, hypersexuality, nightmares, and a rash, The American Journal of Psychiatry, vol.153, issue.4, pp.545-551, 1996.

J. Steiner, H. Bielau, and R. Brisch, Immunological aspects in the neurobiology of suicide : Elevated microglial density in schizophrenia and depression is associated with suicide, Journal of Psychiatric Research, vol.42, issue.2, pp.151-157, 2008.

L. Stertz, P. V. Magalhães, and F. Et-kapczinski, Is bipolar disorder an inflammatory condition ? The relevance of microglial activation, Current Opinion in Psychiatry, vol.26, issue.1, pp.19-26, 2013.

,

R. K. Straubinger, B. A. Summers, and Y. F. Chang, Persistence of Borrelia burgdorferi in experimentally infected dogs after antibiotic treatment, Journal of Clinical Microbiology, vol.35, issue.1, pp.111-116, 1997.

R. B. Stricker, Counterpoint: Long-term antibiotic therapy improves persistent symptoms associated with lyme disease, America, vol.45, issue.2, pp.149-157, 2007.

M. Strnad, V. Hönig, and D. R??ek, Europe-Wide Meta-Analysis of Borrelia burgdorferi Sensu Lato Prevalence in Questing Ixodes ricinus Ticks, Applied and Environmental Microbiology, issue.15, p.83, 2017.

J. R. Sundin, A. R. Øksengård, and L. S. Røste, Tidsskrift for Den Norske Laegeforening: Tidsskrift for Praktisk Medicin, vol.134, pp.1577-1580, 2014.

K. Suzuki, G. Sugihara, and Y. Ouchi, Microglial activation in young adults with autism spectrum disorder, JAMA Psychiatry, vol.70, issue.1, pp.49-58, 2013.

,

W. Swardfager, K. Lanctôt, and L. Rothenburg, A meta-analysis of cytokines in Alzheimer's disease, Biological Psychiatry, vol.68, issue.10, pp.930-941, 2010.

,

R. A. Sykes and P. Et-makiello, An estimate of Lyme borreliosis incidence in Western Europe ?, Journal of Public Health, vol.39, issue.1, pp.74-81, 2017.

,

T. Szul?yk and R. Et-flisiak, Lyme borreliosis, Annals of Parasitology, vol.58, issue.2, pp.63-69, 2012.

F. A. Tager, B. A. Fallon, and J. Keilp, A controlled study of cognitive deficits in children with chronic Lyme disease, The Journal of Neuropsychiatry and Clinical Neurosciences, vol.13, issue.4, pp.500-507, 2001.

N. A. Tetreault, A. Y. Hakeem, and S. Jiang, Microglia in the cerebral cortex in autism, Journal of Autism and Developmental Disorders, vol.42, issue.12, pp.2569-2584, 2012.

,

T. C. Theoharides, A. Angelidou, and K. Alysandratos, Mast cell activation and autism, 2012.

, Biochimica Et Biophysica Acta, vol.1822, issue.1, pp.34-41

T. C. Theoharides, S. Asadi, and A. B. Patel, Focal brain inflammation and autism, Journal of Neuroinflammation, vol.10, 2013.

T. C. Theoharides and B. Zhang, Neuro-inflammation, blood-brain barrier, seizures and autism, Journal of Neuroinflammation, vol.8, p.168, 2011.

J. Treib, M. T. Grauer, and A. Haass, Chronic Fatigue Syndrome in Patients with Lyme Borreliosis, European Neurology, vol.43, issue.2, pp.107-109, 2000.

A. Tversky and D. Et-kahneman, Judgment under Uncertainty: Heuristics and Biases, Science, vol.185, issue.4157, pp.1124-1131, 1974.

R. J. Tynan, J. Weidenhofer, and M. Hinwood, A comparative examination of the antiinflammatory effects of SSRI and SNRI antidepressants on LPS stimulated microglia, Brain, Behavior, and Immunity, vol.26, issue.3, pp.469-479, 2012.

B. N. Van-berckel, M. G. Bossong, and R. Boellaard, Microglia activation in recent-onset schizophrenia: A quantitative (R)-[11C]PK11195 positron emission tomography study, Biological Psychiatry, vol.64, issue.9, pp.820-822, 2008.

H. A. Van-den-bergen, J. P. Smith, and A. Van-der-zwan, , 1993.

, Nederlands Tijdschrift Voor Geneeskunde, vol.137, issue.41, pp.2098-2100

C. Van-den-wijngaard, A. Hofhuis, and A. Wong, The cost of Lyme borreliosis, European Journal of Public Health, vol.27, issue.3, pp.538-547, 2017.

K. Vanthomme, N. Bossuyt, and N. Boffin, Incidence and management of presumption of Lyme borreliosis in Belgium: Recent data from the sentinel network of general practitioners, 2012.

, European Journal of Clinical Microbiology et Infectious Diseases: Official Publication of the European Society of Clinical Microbiology, vol.31, issue.9, pp.2385-2390

M. Vayssier-taussat, S. Moutailler, and L. Michelet, Next Generation Sequencing Uncovers Unexpected Bacterial Pathogens in Ticks in Western Europe, PLOS ONE, vol.8, issue.11, 2013.

. Vercueil, La loi de Brandolini ou le principe d'asymétrie du baratin : un défi pour les scientifiques, 2016.

M. Voitey, K. Bouiller, and J. Moreau, Suspicion de borréliose de Lyme : Parcours de soins avant la consultation en infectiologie et apport de l'infectiologue, vol.48, 2018.

M. Vrethem, L. Hellblom, and M. Widlund, Chronic symptoms are common in patients with neuroborreliosis --a questionnaire follow-up study, Acta Neurologica Scandinavica, vol.106, issue.4, pp.205-208, 2002.

C. Waniek, I. Prohovnik, and M. A. Kaufman, Rapidly progressive frontal-type dementia associated with Lyme disease, The Journal of Neuropsychiatry and Clinical Neurosciences, vol.7, issue.3, pp.345-347, 1995.

H. J. Westervelt and R. J. Mccaffrey, Neuropsychological functioning in chronic Lyme disease, Neuropsychology Review, vol.12, issue.3, pp.153-177, 2002.

M. C. Wichers and M. Maes, The role of indoleamine 2,3-dioxygenase (IDO) in the pathophysiology of interferon-alpha-induced depression, Journal of Psychiatry et Neuroscience: JPN, vol.29, issue.1, pp.11-17, 2004.

J. E. Wiktorowicz and K. V. Et-soman, Discovery of Candidate Biomarkers, Modern Proteomics -Sample Preparation, Analysis and Practical Applications, pp.443-462, 2016.

H. Wilking and K. Stark, Trends in surveillance data of human Lyme borreliosis from six federal states in eastern Germany, Ticks and Tick-Borne Diseases, vol.5, issue.3, pp.219-224, 2009.

,

J. Wimmer and T. Et-quandt, Living in the Risk Society, Journalism Studies, vol.7, issue.2, pp.336-347, 2006.

G. P. Wormser, R. J. Dattwyler, and E. D. Shapiro, The Clinical Assessment, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis: Clinical Practice Guidelines by the Infectious Diseases Society of America, Clinical Infectious Diseases, vol.43, issue.9, pp.1089-1134, 2006.

G. P. Wormser, R. B. Nadelman, and R. J. Dattwyler, Practice Guidelines for the Treatment of Lyme Disease, Clinical Infectious Diseases, issue.Supplement_1, pp.1-14, 2000.

,

G. P. Wormser and E. D. Shapiro, Implications of gender in chronic Lyme disease, Journal of Women's Health, vol.18, issue.6, pp.831-834, 2002.

G. P. Wormser, E. Weitzner, and D. Mckenna, Long-term assessment of health-related quality of life in patients with culture-confirmed early Lyme disease, America, vol.61, issue.2, pp.244-247, 2015.

N. Yiannakoulias, R. Tooby, and S. L. Sturrock, Celebrity over science ? An analysis of Lyme disease video content on YouTube, Social Science et Medicine, vol.191, pp.57-60, 2017.

,

R. Yolken, E. F. Torrey, and F. Et-dickerson, Evidence of increased exposure to Toxoplasma gondii in individuals with recent onset psychosis but not with established schizophrenia, PLoS Neglected Tropical Diseases, vol.11, issue.11, 2017.

S. Zotter, J. Koch, K. Schlachter, and S. Katzensteiner, Neuropsychological profile of children after an episode of neuroborreliosis, Neuropediatrics, vol.44, issue.6, pp.346-353, 2013.

, Enfant de 14 ans et demi atteint ayant eu un développement typique jusqu'à l'âge de 1 an, avant de développer progressivement un TSA après avoir été atteint de la maladie de Lyme. -Après une antibiothérapie de 12 mois, amélioration des interactions sociales, 2012.

R. Bransfield, , 2007.

R. Bransfield, Mécanismes inflammatoires/immunologiques dans les troubles psychiatriques de la maladie de Lyme, 2012.